These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 30676334)
1. CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma: Are CRTC1-TRIM11 Fusion-bearing Tumors Melanocytomas or Clear Cell Sarcomas? Bontoux C; Baroudjian B; Le Maignan C; Vercellino L; Farges C; Guillemot D; Pierron G; Lebbé C; Battistella M Am J Surg Pathol; 2019 Jun; 43(6):861-863. PubMed ID: 30676334 [No Abstract] [Full Text] [Related]
2. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue? Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma. Cellier L; Perron E; Pissaloux D; Karanian M; Haddad V; Alberti L; de la Fouchardière A Am J Surg Pathol; 2018 Mar; 42(3):382-391. PubMed ID: 29240581 [TBL] [Abstract][Full Text] [Related]
4. CRTC1-TRIM11 fusion defined melanocytic tumors: A series of four cases. Ko JS; Wang L; Billings SD; Pissaloux D; Tirode F; Berry R; De La Fouchardiere A J Cutan Pathol; 2019 Nov; 46(11):810-818. PubMed ID: 31237704 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases. Hanna J; Ko JS; Billings SD; Boivin F; Beaudoux O; Pissaloux D; Tirode F; Laga A; Fletcher CDM; de la Fouchardiere A Am J Surg Pathol; 2022 Nov; 46(11):1457-1466. PubMed ID: 35993578 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report. Vest BE; Harview CL; Liu V; Swick BL; Berrebi KG; Olivares S; Stone MS; Sargen MR; Gerami P J Cutan Pathol; 2022 Dec; 49(12):1025-1030. PubMed ID: 35751643 [TBL] [Abstract][Full Text] [Related]
7. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms. Linos K J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report. Duan R; He X; Ma X; Huang F; Hu X Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586 [TBL] [Abstract][Full Text] [Related]
9. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation. Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than indolent? Yang L; Yin Z; Wei J; Chai J; Zhao D; Liu Y; Tang Y; Cheng H; Zhe W; Fan L Histopathology; 2023 Jan; 82(2):368-371. PubMed ID: 36177516 [No Abstract] [Full Text] [Related]
11. CRTC1::TRIM11 cutaneous tumor: An update with local recurrence and lung metastasis in a pediatric patient. Vest BE; Berrebi KG; Stone MS; Sargen MR; Gerami P J Cutan Pathol; 2024 Mar; 51(3):181-183. PubMed ID: 37944913 [No Abstract] [Full Text] [Related]
12. TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system. Ishikawa H; Tachikawa H; Miura Y; Takahashi N FEBS Lett; 2006 Sep; 580(20):4784-92. PubMed ID: 16904669 [TBL] [Abstract][Full Text] [Related]
13. Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity. Parra O; Bridge JA; Busam KJ; Shalin SC; Linos K J Cutan Pathol; 2021 Jul; 48(7):915-924. PubMed ID: 33586183 [TBL] [Abstract][Full Text] [Related]
14. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062 [TBL] [Abstract][Full Text] [Related]
15. Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing. Towery EA; Papke DJ J Clin Pathol; 2023 Dec; 76(12):802-812. PubMed ID: 37550012 [TBL] [Abstract][Full Text] [Related]
16. An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating. Yuan T; Yao W; Tokunaga K; Yang R; Sun B Retrovirology; 2016 Oct; 13(1):72. PubMed ID: 27737691 [TBL] [Abstract][Full Text] [Related]
17. TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy. Liu T; Tang Q; Liu K; Xie W; Liu X; Wang H; Wang RF; Cui J Cell Rep; 2016 Aug; 16(7):1988-2002. PubMed ID: 27498865 [TBL] [Abstract][Full Text] [Related]
18. Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells. Dai X; Geng F; Li M; Liu M Oncol Rep; 2019 Apr; 41(4):2567-2574. PubMed ID: 30816511 [TBL] [Abstract][Full Text] [Related]
19. TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Yin Y; Zhong J; Li SW; Li JZ; Zhou M; Chen Y; Sang Y; Liu L Oncotarget; 2016 Dec; 7(52):86755-86765. PubMed ID: 27888625 [TBL] [Abstract][Full Text] [Related]
20. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53. Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]